For Investors

Relypsa, a Vifor Pharma company, is a wholly-owned member of the Galenica Group. Galenica is a diversified group active throughout the healthcare market that, among other things, develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks. With its two business units Vifor Pharma and Galenica Santé, the Galenica Group enjoys a leading position in all its core business activities. Galenica is listed on the SIX Swiss Stock Exchange. More information on Galenica is available here.

Vifor Pharma, a company of the Galenica Group, is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of prescription medicines as well as over-the-counter products. Vifor Pharma, headquartered in Zurich, Switzerland, has an increasingly global presence and a broad network of affiliates and partners around the world. More information about Vifor Pharma is available here.

Frequently Asked Questions

Here are answers to frequently asked questions from investors.

General Questions

How can I invest in Galenica?
A position in Galenica may be acquired through equities listed on the SIX Swiss Stock Exchange under ticker GALN. More information on investing in Galenica is below or you may visit the Investors section of Galenica’s website here.

Why am I unable to invest in Relypsa directly?
Relypsa is no longer listed on the NASDAQ stock exchange. On September 1, 2016, Relypsa became a Vifor Pharma company. Vifor Pharma is a business unit of the Galenica Group.

Investing in Galenica

What is Galenica’s stock information?
Shares in Galenica are publicly traded on the Swiss stock exchange SIX Swiss Stock Exchange under the symbol GALN and security number 1,553,646 (ISIN CH0015536466). The trading currency is swiss franc or CHF.

Does Galenica have an underlying American Depository Receipt (ADR) program in the United States?
No, shares of Galenica do not trade in the United States as ADRs issued by U.S. depository banks.

Can I invest in Galenica if I’m located outside of Switzerland?
If you are located outside of the local area, contact your broker to confirm they can process your order. If in the United States, the Securities and Exchange Commission provides information on international investing here.

Where can I find information on Galenica’s company dividend and tax value?
As a priority, the Board of Directors of Galenica seeks to maintain an appropriate balance between attractive shareholder returns, investment of the profit in the operational business and a strong capital structure. Dividend history and tax value information is available here.

How can I get copies of Galenica’s Annual Report and other publications?
Galenica shareholder materials are available here.

How can I contact Investor Relations?
Please contact the Galenica Investor Relations team either via email at investors@galenica.com or here.